(Q85207837)
Statements
Analysis of high-dose intravenous immunoglobulin therapy in 16 patients with refractory autoimmune blistering skin disease: high efficacy and no serious adverse events (English)
Vera Seidling
Alexander H Enk
Eva N Hadaschik